Jv. Martinezsuarez et Jl. Rodrigueztudela, IN-VITRO ACTIVITIES OF SEMISYNTHETIC PNEUMOCANDIN L-733,560 AGAINST FLUCONAZOLE-RESISTANT AND FLUCONAZOLE-SUSCEPTIBLE CANDIDA-ALBICANS ISOLATES, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1277-1279
Lipopeptide L-733,560 is a water-soluble derivative of pneumocandin B-
0 that exhibits enhanced anti-Candida activity. We investigated the in
vitro activity of L-733,560 compared with those of amphotericin B, fl
ucytosine, and itraconazole, against fluconazole-resistant (n = 44) an
d fluconazole-susceptible (n = 46) Candida albicans isolates. Tests we
re performed with a photometer-read broth microdilution method with RP
MI-2% glucose and National Committee for Clinical Laboratory Standards
reference strains. Except for those of itraconazole, MICs were not si
gnificantly different between the two groups of isolates, as expected
for agents with different mechanisms of action. L-733,560 was the most
active agent against C. albicans, with MICs for 50 and 90% of the str
ains tested of 0.01 and 0.06 mu g/ml, respectively.